Biotechnologies Assets S.A.
BST.MC
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.74M
Close$
Share Statistics
| Market cap | $15.74 Million |
|---|---|
| Enterprise Value | $17.74 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.82 |
| Outstanding Shares | 72,699,854 |
Return
| Return on Equity | -78.24% |
|---|---|
| Return on Assets | -35.64% |
| Return on Invested Capital | -36.75% |
Valuation & Multiples
| P/E Ratio | -7.72 |
|---|---|
| PEG | 58.95 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.93 |
| Enterprise Value to EBIT | -4.69 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biotechnologies Assets S.A.
26 employees
CEO: Manuel Lopez Nieto Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agricu...